Multiple predictive biomarker testing in melanoma: Another challenge in identifying the optimal approach on cytological samples.

Cytopathology : official journal of the British Society for Clinical Cytology(2023)

引用 0|浏览29
暂无评分
摘要
We highlighted the feasibility of assessing PD-L1 expression levels in residual CB material from metastatic melanomas previously tested for BRAF and NRAS mutations. Moreover, we pointed out that FNC needle rinses may be an alternative source of nucleic acids for molecular testing, preserving CB material for immunocytochemistry evaluation.
更多
查看译文
关键词
PD-L1,fine needle cytology,immunotherapy,melanoma,molecular biology
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要